Want to see OSCR full AI Analyst Report?
OSCR Stock Chart & Stats
$30.93
$0.77(2.73%)
At close: 4:00 PM EDT
$30.93
$0.77(2.73%)
Day’s Range― - ―
52-Week Range$10.69 - $34.48
Previous CloseN/A
Volume8.39K
Average Volume (3M)5.06M
Market Cap
$10.30B
Enterprise Value$9.94B
Total Cash (Recent Filing)$8.56B
Total Debt (Recent Filing)$431.63M
Price to Earnings (P/E)19.5
Beta0.78
Next Earnings
Nov 05, 2026EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.71
Shares Outstanding273,469,000
10 Day Avg. Volume4,492,247
30 Day Avg. Volume5,058,326
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.86
Price to Sales (P/S)0.32
P/FCF Ratio3.56
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue0.65
Enterprise Value/Gross Profit1.44
Enterprise Value/Ebitda15.69
Forecast
1Y Price Target
$35.78Price Target Upside15.67% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)1.91
Revenue Forecast (FY)$18.66B
Bulls Say, Bears Say
Bulls Say
Membership And Revenue ExpansionRapid membership growth is expanding Oscar’s premium base and supporting substantial revenue scale. The combination of above-market enrollment, solid retention, and reaffirmed 2026 revenue guidance indicates stronger market penetration that can support operating leverage over the next several quarters.
Strong Liquidity And Cash GenerationSubstantial operating cash flow, free cash flow, and liquidity give Oscar resources to fund growth, absorb claims volatility, and invest in technology without relying heavily on external capital. The strengthened capital position also improves resilience as membership and the insurance platform continue to scale.
Technology-driven Operating EfficiencyTechnology and AI are producing measurable administrative and claims-processing benefits, helping Oscar lower its expense burden while supporting a digital member experience. If these tools scale across pharmacy and medical economics, they can create recurring efficiency gains and reinforce the company’s operating model.
Bears Say
Profitability Remains InconsistentThe return to positive earnings is encouraging, but Oscar has not yet demonstrated stable profitability across reporting periods. Prior losses and thin current margins leave less protection against medical-cost pressure, making sustained earnings dependent on continued underwriting and expense improvements.
CMS-related Membership Churn RiskPotential disenrollments could reduce Oscar’s membership base and disrupt the revenue and risk mix assumed in its outlook. Although the company has incorporated the issue into guidance, uncertainty around CMS reviews and the scale of affected members could weigh on growth and increase execution demands.
Medical-cost And Utilization PressurePersistently elevated utilization can pressure the spread between premiums and medical claims, particularly when seasonal deductible effects raise per-member costs. This creates a structural challenge for underwriting margins and requires Oscar’s pricing, network management, and care-navigation initiatives to keep pace.
Oscar Health News
OSCR FAQ
What was Oscar Health’s price range in the past 12 months?
Oscar Health lowest stock price was $10.69 and its highest was $34.48 in the past 12 months.
What is Oscar Health’s market cap?
Oscar Health’s market cap is $10.30B.
When is Oscar Health’s upcoming earnings report date?
Oscar Health’s upcoming earnings report date is Nov 05, 2026 which is in 24 days.
How were Oscar Health’s earnings last quarter?
Oscar Health released its earnings results on Aug 06, 2026. The company reported $1.1 earnings per share for the quarter, beating the consensus estimate of $0.403 by $0.697.
Is Oscar Health overvalued?
According to Wall Street analysts Oscar Health’s price is currently Undervalued.
Does Oscar Health pay dividends?
Oscar Health does not currently pay dividends.
What is Oscar Health’s EPS estimate?
Oscar Health’s EPS estimate is -0.14.
How many shares outstanding does Oscar Health have?
Oscar Health has 273,469,000 shares outstanding.
What happened to Oscar Health’s price movement after its last earnings report?
Oscar Health reported an EPS of $1.1 in its last earnings report, beating expectations of $0.403. Following the earnings report the stock price went down -11.857%.
Which hedge fund is a major shareholder of Oscar Health?
Currently, no hedge funds are holding shares in OSCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oscar Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$35.78 (15.67% Upside)
$35.78 (15.67% Upside)
Blogger Sentiment
Bullish
OSCR Sentiment 89%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $23.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.1%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
62.46%
12-Months-Change
Fundamentals
Return on Equity
38.53%
Trailing 12-Months
Asset Growth
78.15%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Oscar Health
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
OSCR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys materially positive operating momentum: very strong revenue growth, sizeable membership expansion, record-low SG&A, marked improvement in profitability metrics and a raised earnings outlook. Management also emphasized technology and AI-driven efficiency gains and favorable risk‑adjustment developments that underpin the improved guidance. Offsetting items include an ongoing industry-wide ACA market contraction, elevated outpatient utilization and medical PMPM seasonality, and near-term uncertainty from CMS eligibility/program-integrity actions and limited early-year morbidity data. On balance, the positive operational and financial drivers substantially outweigh the risks flagged for the back half of the year.View all OSCR earnings summariesOSCR Stock 12 Month Forecast
Average Price Target
$35.78
▲(15.67% Upside)
Technical Analysis
Centene
―
Humana
―
Molina Healthcare
―
Clover Health Investments
―
Alignment Healthcare
―
Ownership Overview
4.36% Insiders
16.17% Mutual Funds
0.53% Other Institutional Investors
59.49% Public Companies and Individual Investors